Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295851570> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W4295851570 abstract "Purpose Crizotinib has been one of the standard treatment options for the treatment of anaplastic lymphoma kinase (ALK) rearranged non-small cell lung cancer (NSCLC) based on higher progression-free survival (PFS) and objective response rates in phase III clinical trials. However, real-world data about the long-term efficacy and toxicity of crizotinib is limited. Methods A retrospective analysis of all patients with ALK-positive NSCLC, treated with crizotinib between March 2014 and December 2016, was performed. The main outcomes measured were PFS, overall survival (OS), and adverse effects. Results One hundred and eighty-eight patients treated with crizotinib during this period were included in this study. The median age was 50 years (range: 24–74) with a majority being males (73.2%) and 80.3% with a performance status of 0 to 1. The median duration of follow-up was 49.4 months (range: 3.4–86.3%). The median PFS of crizotinib was 17.3 months (95% confidence interval [CI], 13.0–21.6) and 12.8 months (95% CI, 8.1–17.6) when used in first line or subsequent lines, respectively. The median OS was 38.3 months (95% CI, 28.4–48.2). The patients who received crizotinib in the first line had a median OS of 45.5 months (95% CI, 29.6–61.4) as compared with 29.7 months (95% CI, 22.2–37.2) for those who received in subsequent line (hazard ratio, 0.6, 95% CI, 0.4–0.9, p=0.022). The most common all grade toxicities include transaminitis, anemia, fatigue, and corrected QT prolongation. Conclusion This real-world study confirms the long-term beneficial effects of crizotinib in ALK rearranged NSCLC with favorable toxicity profile like that of the registration studies, in resource constrained settings." @default.
- W4295851570 created "2022-09-15" @default.
- W4295851570 creator A5003412464 @default.
- W4295851570 creator A5015218027 @default.
- W4295851570 creator A5026250879 @default.
- W4295851570 creator A5027531002 @default.
- W4295851570 creator A5031219890 @default.
- W4295851570 creator A5031521610 @default.
- W4295851570 creator A5080969238 @default.
- W4295851570 creator A5083740633 @default.
- W4295851570 creator A5086083991 @default.
- W4295851570 creator A5089100168 @default.
- W4295851570 date "2022-09-02" @default.
- W4295851570 modified "2023-09-25" @default.
- W4295851570 title "Long-Term Outcomes of Crizotinib Treated ALK-Positive Lung Cancer Patients: A Retrospective Audit of Prospective Data from Resource-Constrained Settings" @default.
- W4295851570 cites W2050249255 @default.
- W4295851570 cites W2099530756 @default.
- W4295851570 cites W2519311038 @default.
- W4295851570 cites W2766602847 @default.
- W4295851570 cites W2790791873 @default.
- W4295851570 cites W2954719002 @default.
- W4295851570 cites W2975140915 @default.
- W4295851570 cites W3011515154 @default.
- W4295851570 doi "https://doi.org/10.1055/s-0042-1753478" @default.
- W4295851570 hasPublicationYear "2022" @default.
- W4295851570 type Work @default.
- W4295851570 citedByCount "1" @default.
- W4295851570 countsByYear W42958515702023 @default.
- W4295851570 crossrefType "journal-article" @default.
- W4295851570 hasAuthorship W4295851570A5003412464 @default.
- W4295851570 hasAuthorship W4295851570A5015218027 @default.
- W4295851570 hasAuthorship W4295851570A5026250879 @default.
- W4295851570 hasAuthorship W4295851570A5027531002 @default.
- W4295851570 hasAuthorship W4295851570A5031219890 @default.
- W4295851570 hasAuthorship W4295851570A5031521610 @default.
- W4295851570 hasAuthorship W4295851570A5080969238 @default.
- W4295851570 hasAuthorship W4295851570A5083740633 @default.
- W4295851570 hasAuthorship W4295851570A5086083991 @default.
- W4295851570 hasAuthorship W4295851570A5089100168 @default.
- W4295851570 hasBestOaLocation W42958515701 @default.
- W4295851570 hasConcept C117643217 @default.
- W4295851570 hasConcept C126322002 @default.
- W4295851570 hasConcept C141071460 @default.
- W4295851570 hasConcept C143998085 @default.
- W4295851570 hasConcept C167135981 @default.
- W4295851570 hasConcept C197934379 @default.
- W4295851570 hasConcept C207103383 @default.
- W4295851570 hasConcept C2776232967 @default.
- W4295851570 hasConcept C2776256026 @default.
- W4295851570 hasConcept C2776694085 @default.
- W4295851570 hasConcept C2778347629 @default.
- W4295851570 hasConcept C2779422266 @default.
- W4295851570 hasConcept C2780739268 @default.
- W4295851570 hasConcept C44249647 @default.
- W4295851570 hasConcept C71924100 @default.
- W4295851570 hasConceptScore W4295851570C117643217 @default.
- W4295851570 hasConceptScore W4295851570C126322002 @default.
- W4295851570 hasConceptScore W4295851570C141071460 @default.
- W4295851570 hasConceptScore W4295851570C143998085 @default.
- W4295851570 hasConceptScore W4295851570C167135981 @default.
- W4295851570 hasConceptScore W4295851570C197934379 @default.
- W4295851570 hasConceptScore W4295851570C207103383 @default.
- W4295851570 hasConceptScore W4295851570C2776232967 @default.
- W4295851570 hasConceptScore W4295851570C2776256026 @default.
- W4295851570 hasConceptScore W4295851570C2776694085 @default.
- W4295851570 hasConceptScore W4295851570C2778347629 @default.
- W4295851570 hasConceptScore W4295851570C2779422266 @default.
- W4295851570 hasConceptScore W4295851570C2780739268 @default.
- W4295851570 hasConceptScore W4295851570C44249647 @default.
- W4295851570 hasConceptScore W4295851570C71924100 @default.
- W4295851570 hasLocation W42958515701 @default.
- W4295851570 hasOpenAccess W4295851570 @default.
- W4295851570 hasPrimaryLocation W42958515701 @default.
- W4295851570 hasRelatedWork W2318061299 @default.
- W4295851570 hasRelatedWork W2400744927 @default.
- W4295851570 hasRelatedWork W2516942920 @default.
- W4295851570 hasRelatedWork W2624310346 @default.
- W4295851570 hasRelatedWork W2811223828 @default.
- W4295851570 hasRelatedWork W2941535758 @default.
- W4295851570 hasRelatedWork W2982087753 @default.
- W4295851570 hasRelatedWork W3197633853 @default.
- W4295851570 hasRelatedWork W3199005851 @default.
- W4295851570 hasRelatedWork W2970177775 @default.
- W4295851570 isParatext "false" @default.
- W4295851570 isRetracted "false" @default.
- W4295851570 workType "article" @default.